Search Results for: covid-19
Articles
April 9, 2020
Precision BioSciences Announces Dosing of First Patient in Phase 1/2a Clinical Trial
Precision BioSciences, Inc. recently announced the initiation of patient dosing in a Phase 1/2a clinical trial of its second off-the-shelf (allogeneic) chimeric….
April 9, 2020
Antiviral Drugs Market to Foresee Tremendous Gains Over 2020-2026
The global antiviral drugs market was valued at $56 billion in 2019 and is expected to accrue phenomenal gains over...
April 1, 2020
Aravive Announces AVB-500 Improves Anti-Tumor Effects When Combined With Anti-Angiogenic Bevacizumab or PARP Inhibitor Olaparib
Aravive, Inc. recently announced that AVB-500 improves anti-tumor effects when combined with the anti-angiogenic bevacizumab or the PARP inhibitor olaparib...
April 1, 2020
Carterra Selected by La Jolla Institute of Immunology to Provide Antibody Screening & Characterization for the Coronavirus Immunotherapy Consortium (CoVIC)
Carterra Inc. and La Jolla Institute for Immunology (LJI), announced today that they will use Carterra’s proprietary LSA platform to...
March 25, 2020
Akers Biosciences Acquires Licenses to Coronavirus Vaccine Candidate From Premas Biotech
Akers Biosciences, Inc. recently announced it has acquired a licensing agreement with Premas Biotech, under which Akers will in-license a novel coronavirus vaccine candidate under development by…..
March 25, 2020
WPD Pharmaceuticals Partners With CNS Pharmaceuticals on Drug Development for Coronavirus & Other Antiviral Indications
WPD Pharmaceuticals Inc. recently announced it has entered into a development agreement with CNS Pharmaceuticals, Inc. for the development of……
March 25, 2020
Novavax’s NanoFlu Achieves All Primary Endpoints In Phase 3 Clinical Trial
Novavax, Inc. recently announced positive top-line results of its pivotal Phase 3 clinical trial of NanoFlu, its recombinant quadrivalent seasonal...
March 25, 2020
Rafael Pharmaceuticals Enrolls More Than 75% of Patients Needed for Pivotal Phase 3 Trial
Rafael Pharmaceuticals, Inc. recently announced it has enrolled more than 75% of the 500 patients needed for its pivotal Phase...
March 19, 2020
Enlivex Announces Positive Final Safety & Efficacy Data From Clinical Trial
Enlivex Therapeutics Ltd. recently announced positive final safety and efficacy data from the company’s completed Phase 1b clinical trial in...
March 12, 2020
Emergent BioSolutions Initiates Development of Plasma-Derived Product Candidates for the Treatment & Prevention of Coronavirus Disease
Emergent BioSolutions Inc. recently announced it has initiated development of two product candidates for the treatment and prevention of coronavirus...
